Palmetto Retina Center | ClinicalTrials HQ

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME	diabetic macular edema	Active, not recruiting	Phase 3	2026-10-08		NCT04108156
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy	Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder	Recruiting	Phase 3	2026-09-18		NCT06541704
A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)	diabetic macular edema	Active, not recruiting	Phase 3	2026-09-18		NCT06491914
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD	Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder	Recruiting	Phase 2	2026-09-10		NCT06659445
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)	Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degeneration	Recruiting	Phase 2 / Phase 3	2026-08-06		NCT07496567
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration	eye disorder, macular degeneration, retinal degeneration, retinal disorder, wet macular degeneration	Active, not recruiting	Phase 3	2026-06-01		NCT06864988
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK	Wet Age-related Macular Degeneration	Active, not recruiting	Phase 3	2026-04-29		NCT06556368
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration	eye disorder, macular degeneration, retinal degeneration, retinal disorder, wet macular degeneration	Recruiting	Phase 3	2026-04-16		NCT07064759